Cost-effectiveness of vagus nerve stimulation therapy for drug-resistant epilepsy across healthcare settings: a structured narrative review
Abstract Drug-resistant epilepsy (DRE) is associated with substantial healthcare utilization, impaired quality of life (QOL), and considerable societal costs. Vagus nerve stimulation (VNS) has become an established adjunctive treatment for patients who are not suitable candidates for resective epilepsy surgery or who f...